专利详细信息
专利号 | USRE44186E1 |
专利标题 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method |
专利权人 | BRISTOL-MYERS SQUIBB COMPANY; |
发明人 | Robl, Jeffrey A;Sulsky, Richard B;Augeri, David J;Magnin, David R;Hamann, Lawrence G;Betebenner, David A; |
申请号 | US13/308658 |
申请日 | 2011/12/1 |
公开日 | 2013/4/30 |
优先权号 | |
IPC | C07D20902000; |
专利类型 | |
法律状态查询 | 查看法律状态 |
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula where x is 0 or 1 and y is 0 or 1 (provided that x=1 when y=0 and x=0 when y=1); n is 0 or 1; X is H or CN; and wherein R1 R2 R3 and R4 are as described herein. A method is also provided for treating diabetes and related diseases especially Type II diabetes and other diseases as set out herein employing such DP 4 inhibitor *or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin glyburide troglitazone pioglitazone rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。